Company Filing History:
Years Active: 2002
Title: **Innovative Contributions of Inventor Mary Shu Mai Leet**
Introduction
Mary Shu Mai Leet, based in Flemington, Australia, is an accomplished inventor known for his significant contributions to the field of immunology. With a focus on addressing global health challenges, Leet has made strides in malaria research, particularly in the development of vaccines.
Latest Patents
Leet holds one patent, titled "Malaria merozoite antigen subunit vaccine." This patent describes an immunogenic polypeptide designed to induce an immune response against Plasmodium infection. The polypeptide comprises an amino acid sequence that corresponds to a non-full length fragment of the apical membrane antigen 1 (AMA-1) of Plasmodium species. Importantly, it does not include the transmembrane domain, and it is stabilised through proper folding. The patent details the production of this immunogenic polypeptide by expressing a recombinant DNA molecule within a host cell, as well as the methods and compositions that utilize this innovative polypeptide.
Career Highlights
Throughout his career, Leet has contributed to advancements in vaccine development and infectious disease research. His work has been crucial in understanding the mechanisms of malaria, which affects millions globally. His innovative approaches aim to enhance the efficacy of vaccines and provide new avenues for treatment.
Collaborations
Mary Shu Mai Leet has collaborated with esteemed colleagues, including Robin Fredric Anders and Pauline Elizabeth Crewther. These collaborations have facilitated groundbreaking research and the sharing of knowledge within the scientific community, ultimately amplifying the impact of their collective work on public health.
Conclusion
In summary, Mary Shu Mai Leet's innovative endeavors in vaccine development demonstrate the vital role inventors play in tackling complex health issues. His patent on the malaria merozoite antigen subunit vaccine illustrates the potential of scientific research to create effective solutions against infectious diseases like malaria. As Leet continues his work at Saramane Pty., Ltd., the future of malaria prevention looks promising.